Across TCGA pan-cancer cohorts, SNORA11C RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SNORA11C data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SNORA11C RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORA11C expression acts as an unfavorable survival marker.
ACC, SKCM, and COAD are the cancer types where SNORA11C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.